Lucy Scientific Discovery Inc. (LSDI)
Lucy Scientific Discovery Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Victoria, BC, CA. The stock last traded at $0.51, down 23.29% on the session, giving a market capitalisation of $906,910. On trailing twelve-month figures it carries a trailing P/E of -0.72, a net margin of -127532.0%. Its beta of 0.71 implies it has historically moved less than the broad market.
Lucy Scientific Discovery Inc. focuses on the entire lifecycle of psychedelic products, from their initial research and development to their production and subsequent market release. The company's offerings include fundamental biological raw materials, unprocessed extracts, a variety of psychotropic compounds, and critical active pharmaceutical ingredients (APIs). Established in 2017, this firm, formerly known as Hollyweed North Cannabis, Inc., is headquartered in Victoria, Canada.
Lucy Scientific Discovery Inc. is most often compared with the following Healthcare names: